Format

Send to

Choose Destination
Liver Int. 2018 Feb;38 Suppl 1:40-46. doi: 10.1111/liv.13668.

Is global elimination of HCV realistic?

Author information

1
Sezione di Gastroenterologia & Epatologia, DIBIMIS, Università di Palermo, Palermo, Italy.

Abstract

The elimination of hepatitis C virus (HCV) has been made possible through the availability of new antiviral drugs which may now be administered to all patients with HCV infection, even those with decompensated cirrhosis. The goal of the World Health Organization (WHO) is to reduce the incidence of chronic hepatitis infection from the current 6-10 million to 0.9 million cases of chronic infections by 2030, and annual deaths from 1.4 million to fewer than 0.5 million. Achieving these targets will require full implementation of epidemiological knowledge of HCV infection, screening and testing practices and strategies to link HCV patients to care. This review will focus on the current state of knowledge in the epidemiology of HCV and what can be done to increase patient awareness and reduce the barriers to treatment. Furthermore, we will discuss the role of HCV clearance on the control of HCV-related outcomes.

KEYWORDS:

direct antiviral agents; linkage to care; screening

PMID:
29427499
DOI:
10.1111/liv.13668

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center